Point-of-care triage and thermal treatment for cervical precancer with the IRIS device
Official title: POINT of CARE - Providing an Innovative New Triage and Treatment Strategy for Cervical Cancer Screening Efficiency
Run by Basic Health International, Inc. · NCT07461818 · Data updated 2026-11-12
This project tests a portable thermal ablation device plus an AI image triage tool to treat and prioritize HPV-positive women aged 30–49 with cervical precancer in El Salvador.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 49 Years |
| Sex | Women only |
| Enrollment | 5000 (estimated) |
| Sponsor | Basic Health International, Inc. Academic / other |
| Locations | 1 site (San Salvador, San Salvador Department) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | January 2029 |
| Study ends | August 2029 |
| Registry record updated | August 28, 2026 |
| Trial ID | NCT07461818 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are non-pregnant women aged 30–49 who are HPV-positive through the national program, willing to undergo colposcopy and biopsies, and able to provide reliable contact information and informed consent.
✕Probably not a fit
Patients unlikely to benefit include pregnant women, those planning pregnancy during the study, individuals with recent LEEP or prior hysterectomy, women with a history of cervical cancer, HPV-negative people, or those unable to complete follow-up.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study prospectively enrolls 5,000 HPV-positive women aged 30–49 in El Salvador to receive a modified two-probe thermal ablation using the IRIS™ device with colposcopy and biopsies. The primary aim is to estimate one-year cure rates for CIN2+ after treatment with the modified IRIS probes in a single-arm interventional cohort. A retrospective component will apply an AI-based Automated Visual Evaluation (AVE) algorithm to IRIS images and compare its diagnostic performance against histopathology. Results will inform whether the probe modification improves treatment effectiveness and whether AVE could better identify women who need treatment.
Why it matters
Potential benefit: If successful, this approach could expand access to effective same-day treatment and reduce progression to cervical cancer in low-resource settings.
How similar studies have gone: Portable thermal ablation has prior data showing safety and effectiveness in low-resource settings, while AVE-style AI triage methods are promising but still require independent validation against histopathology.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 30-49 years * Non-pregnant (determined by urine pregnancy test) * HPV-positive per Ministry of Health (MOH) records * Willing to undergo colposcopy and biopsies * Able and willing to provide informed consent Exclusion Criteria: * Plans to become pregnant during the study * History of LEEP or cervical ablation procedure in the past 5 years * History of total hysterectomy (verified by medical record or pelvic evaluation) * History of cervical cancer * Unable or unwilling to provide a permanent and reliable address * Unable or unwilling to provide informed consent
Where it's running
-
Basic Health International
San Salvador, San Salvador Department, El Salvador Recruiting
Study contacts
- Principal investigator: Karla Alfaro, MD — Basic Health International, Inc.
- Study coordinator: Karla Alfaro, MD
- Email: kalfaro@basichealth.org
- Phone: +503 22838731
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lived experiences of women with HPV infection
This study talks with women who have HPV to hear in their own words how the infection affects daily life, relationships, and what information or support they wish they had.
-
Two-probe thermal ablation for cervical precancer in WLWH in South Africa
This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.
-
Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe
This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.
-
Same-day HPV self-testing with digital cytology triage in Cameroon
This project will test whether HPV self-sampling followed by same-day digital telecytology can quickly find which HPV-positive women aged 30–49 (25–49 if HIV-positive) in Cameroon need treatment.
-
Two-probe thermal ablation for cervical precancer in HIV+ women in Kenya
This study tests whether using two probes for thermal ablation is more effective and acceptable than one probe for treating cervical precancer in women living with HIV in Kenya.
-
Two-probe thermal ablation for cervical precancer in WLWH in Rwanda
This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in Rwanda.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.